Neurosteer Bedside Monitoring System

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
DeliriumSedationAgitation
Interventions
DEVICE

Neurosteer's single-channel EEG monitoring device

"Neurosteer device will be attached to participants forehead and readings will be collected for the duration of their NSICU stay.~Neurosteer auditory stimulation will be done 3-4 times a day to coincide with RASS and 1-2 times a day to coincide with CAM-ICU. The research team will correlate collected hourly RASS and CAM-ICU assessments with Neurosteer derived signals and parameters."

Trial Locations (1)

10029

RECRUITING

Mount Sinai Hospital, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Neurosteer Ltd.

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER